Estrogen on TRT: Why Your Doctor's Aromatase Inhibitor Prescription Might Be the Worst Advice You Got

If you're on TRT, there's a good chance your clinic also prescribed an aromatase inhibitor (AI) — anastrozole or exemestane — to "manage your estrogen." The logic sounds reasonable: testosterone converts to estradiol via the aromatase enzyme, and high estrogen in men causes gynecomastia, water retention, and mood issues. Block the conversion, problem solved.

Except the latest clinical evidence suggests that for most men on TRT, reflexive AI use causes more problems than it prevents. And crashing your estradiol may be worse than letting it run high.

Why Estrogen Matters for Men

Estradiol in men isn't a waste product — it's essential. It plays critical roles in bone mineral density (men with crashed estradiol develop osteoporosis), cardiovascular health (estradiol is cardioprotective), brain function (memory, mood regulation), lipid metabolism, and yes, libido. Many symptoms attributed to "high estrogen" in men — including low libido — are actually symptoms of crashed estradiol from overzealous AI use.

The ideal estradiol range on TRT isn't zero — it's proportional to testosterone. Most endocrinologists now recommend targeting estradiol in the 20-40 pg/mL range for men on TRT, with intervention only when symptoms and labs both indicate a problem.

The AI Side Effect Profile

Men on aromatase inhibitors commonly report joint pain and stiffness (the most frequent complaint), mood disturbances including depression and irritability, fatigue and brain fog, decreased libido (the opposite of what they expected), and increased cardiovascular risk from impaired lipid metabolism.

These side effects often get attributed to the TRT itself, when they're actually caused by the AI that was added to "optimize" the protocol. Stopping the AI while continuing TRT frequently resolves these symptoms.

When an AI Actually Makes Sense

There are legitimate indications for AI use on TRT, but they're narrower than current practice suggests. Documented gynecomastia with tissue growth (not just nipple sensitivity, which is often transient), estradiol consistently above 50-60 pg/mL with symptoms, or significant fluid retention that doesn't respond to dose adjustment may warrant AI use at the lowest effective dose.

The key change in thinking: treat symptoms, not numbers. An estradiol of 45 pg/mL in a man who feels great doesn't need an AI, regardless of what a reference range says.